139 related articles for article (PubMed ID: 20216231)
1. Low level of serum interleukin 27 in patients with systemic lupus erythematosus.
Li TT; Zhang T; Chen GM; Zhu QQ; Tao JH; Pan HF; Ye DQ
J Investig Med; 2010 Jun; 58(5):737-9. PubMed ID: 20216231
[TBL] [Abstract][Full Text] [Related]
2. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
3. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients.
Pan HF; Wu GC; Fan YG; Leng RX; Peng H; Zhou M; Li BZ; Zhu Y; Tao JH; Li XP; Ye DQ
Rheumatol Int; 2013 Sep; 33(9):2337-42. PubMed ID: 23539271
[TBL] [Abstract][Full Text] [Related]
5. Increased serum interleukin 17 in patients with systemic lupus erythematosus.
Zhao XF; Pan HF; Yuan H; Zhang WH; Li XP; Wang GH; Wu GC; Su H; Pan FM; Li WX; Li LH; Chen GP; Ye DQ
Mol Biol Rep; 2010 Jan; 37(1):81-5. PubMed ID: 19347604
[TBL] [Abstract][Full Text] [Related]
6. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
7. Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus.
Ouyang H; Shi YB; Liu ZC; Wang Z; Feng S; Kong SM; Lu Y
Am J Med Sci; 2014 Aug; 348(2):156-61. PubMed ID: 25054737
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
El-Banna HS; El Khouly RM; Gado SE
Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
11. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients.
Duarte AL; Dantas AT; de Ataíde Mariz H; dos Santos FA; da Silva JC; da Rocha LF; Galdino SL; Galdino da Rocha Pitta M
Mol Biol Rep; 2013 Aug; 40(8):4889-92. PubMed ID: 23645091
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis.
Xia LP; Li BF; Shen H; Lu J
Scand J Rheumatol; 2015 May; 44(3):200-5. PubMed ID: 25562331
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of IL-24 in systemic lupus erythematosus patients.
Li RC; Guo J; Su LC; Huang AF
Lupus; 2019 May; 28(6):748-754. PubMed ID: 31023128
[TBL] [Abstract][Full Text] [Related]
16. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
17. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
18. Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus.
Peliçari Kde O; Postal M; Sinicato NA; Peres FA; Fernandes PT; Marini R; Costallat LT; Appenzeller S
Clinics (Sao Paulo); 2015 May; 70(5):313-7. PubMed ID: 26039945
[TBL] [Abstract][Full Text] [Related]
19. Increased IL-23R
Izati AF; Mohd Shukri ND; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():690908. PubMed ID: 34484186
[TBL] [Abstract][Full Text] [Related]
20. Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus.
Jin L; Bai R; Zhou J; Shi W; Xu L; Sheng J; Peng H; Jin Y; Yuan H
Med Sci Monit Basic Res; 2018 Oct; 24():168-176. PubMed ID: 30348938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
